Scientific & Technical
Test the underlying biological rationale, technology, performance claims, development maturity, evidence quality, and unresolved technical risks.
For investors, boards & transaction teams
Independent assessment of evidence sufficiency, development risk, and value assumptions.
Technical diligence, scrutiny-ready rationale, and explicit uncertainty and decision implications for consequential capital decisions.
Fiduciary decision support
See the whole investment thesis—not isolated pieces.
Life-science opportunities are rarely won or lost on one variable. A compelling technology may face an impractical regulatory pathway. A credible product may address the wrong workflow. A large market may depend on evidence, adoption, or reimbursement assumptions that have not been tested.
Swerve integrates these dimensions into a clear, decision-oriented view of the opportunity, material risks, critical unknowns, and credible routes forward.
Regulatory & Clinical
Assess pathway assumptions, classification, agency strategy, evidence requirements, clinical plans, claims potential, timelines, and approval risk.
Market & Competitive
Frame the addressable need, clinical workflow, customer and stakeholder landscape, competing technologies, differentiation, adoption barriers, and commercial potential.
Execution & Value Creation
Evaluate team capabilities, development plans, resource requirements, milestones, dependencies, capital efficiency, and the credibility of the path to value.
Where we add value
Support across the investment lifecycle.
Engagements can be rapid and focused or broad and multidisciplinary, depending on the decision, stage, and level of uncertainty.
- Pre-investment and transaction diligence
- Portfolio-company technical and regulatory assessment
- Market, competitor, and opportunity analysis
- Development-plan, budget, and timeline challenge
- Board and investment-committee decision support
- Partnership, licensing, and acquisition evaluation
- Risk identification, prioritization, and mitigation planning
- Post-investment milestone and value-creation advisory
A disciplined outside perspective
Better questions. Clearer risks. More informed decisions.
Our role is not to validate a preferred conclusion. It is to provide an independent, evidence-grounded assessment that helps investment teams fulfill their decision-making and fiduciary responsibilities with greater clarity.
Discuss an investment need ↗